Comerica Bank
PVLA

Comerica Bank’s Palvella Therapeutics PVLA Stock Holding History

Comerica Bank’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.97K Hold
57
– – ﹤0.01% 3370
2025
Q3 		$3.57K Buy
+57
New +$2.54K ﹤0.01% 3459

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Comerica Bank's PVLA Position: Q4 2025 in Review

Comerica Bank held its Palvella Therapeutics (PVLA) position steady in Q4 2025 at 57 shares worth $5.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3370.

Comerica Bank first reported a position in PVLA in Q3 2025 and has held it in 2 quarters since. 140 funds tracked by Wall St. Rank hold PVLA as of Q4 2025.

  • Comerica Bank held 57 shares of Palvella Therapeutics worth $5.97K as of Q4 2025.
  • Comerica Bank left its Palvella Therapeutics share count unchanged in Q4 2025.
  • Palvella Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3370 holding.
  • Comerica Bank first reported a position in Palvella Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 140 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.